B5.082 Prework 1: Hematuria: Benign Causes Flashcards

(48 cards)

1
Q

process of microscopic urinalysis

A

10 mL of midstream clean catch specimen is centrifuged for 10 min at 2000 rpm
3 or more rbc per hpf

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

does excessive anticoagulation lead to hematuria?

A

no

but may make degree and duration worse

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

overview of the steps taken when evaluating microscopic hematuria

A
  1. dipstick
  2. microscopic urinalysis
  3. assess for UTI or benign causes
  4. renal function testing
  5. CT urography
  6. cystoscopy
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

categories of evaluation

A
medical history
physical exam
lab workup
upper tract imaging
lower tract imaging
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

risk factors for urinary tract malignancy

A
> 35 years
analgesic abuse
chemicals/dyes
male sex
smoking
history of: indwelling foreign body, chronic UTI, known carcinogens, gross hematuria, irritative voiding, pelvic irradiation, urologic disorder/disease
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

important components of physical in analysis of hematuria

A
BP
edema
cardiac arrhythmia
CVA tenderness
DRE
pelvic exam
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

components of a urinalysis

A

RBCs
WBCs
presence of bacteria
nitrites

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

what do you do if infection is suspected?

A

urine culture must be sent to confirm infection

UA must be repeated after treatment

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

components of a lab workup for microscopic hematuria

A

UA
culture?
renal function studies
PSA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

alternatives to CT urography for imaging

A

MRI
US
non-contrast CT
retrograde pyelography

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

mechanism for evaluation of lower urinary tract

A

cystoscopy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

most common benign etiologies of microscopic hematuria

A

idiopathic : 43-68%
UTI: 4-22%
urolithiasis: 4-5%
BPH: 10-13%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

uncomplicated UTI

A

infection in a healthy patient with functionally normal urinary tract

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

complicated UTI

A

infection associated with anatomic/functional abnormality of urinary tract, immunocompromised host, or MDR bacteria

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

risk factors for UTI

A

reduced urine flow
colonization
facilitation of ascent (catheter, incontinence)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

host factors that can predispose to UTI

A
changes in estrogen, low vaginal pH
high urine glucose
obstruction
vesicoureteral reflux
immunocompromised
pregnancy
SCI
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

which bacterial factor is associated with pyelonephritis?

A

type P pili/fimbrae

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

use of UA in suspected URI

A

catheterized urine is best
dipstick urinalysis rules infection out not in
nitrite positivity is very specific
pyuria (>10 WBC/hpf) is most sensitive for UTI

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

quantitative urine culture in UTI

A

100,000 CFU is diagnostic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

indications for imaging in UTI evaluation

A
persistence after treatment
sepsis from urinary source
history of urolithiasis
neurogenic bladder
poor response to therapy
infections with urea-splitting bacteria
recurrence with same or unusual strain
21
Q

DOC for uncomplicated UTI

A

nitrofurantoin 100 mg BID x 5 days

TMP/SMX BID x 3 days

22
Q

outpatient management of complicated UTI

A

Cipro BID x 7 days
Levaquin x 5 days
TMP/SMX BID x 14 days
one time IV then 14 day oral ttx

23
Q

inpatient management of complicated UTI

A
IV fluoro
aminoglycoside + ampicillin
3rd gen ceph
extended spectrum pen
carbapenem
switch from parenteral to oral in 48 hours if clinical improvement, treat for 14 days
24
Q

pathophys of urolithiasis

A

soluble urine metabolites occur in amounts too high to stay dissolved in urine
supersaturation allows precipitation and aggregation to form crystalline concentrations
obstruction from a stone can cause pain via ureteral dilation

25
common types of stones
``` calcium oxalate uric acid struvite calcium phosphate cystine ```
26
calcium oxalate stones
most common urinary citrate is an inhibitor risk factors: dehydration, hypercalciuria, hyperoxaluria, hypernatriuria, hyperuricosuria treatment: fluids, decreased Ca in urine, increasing citrate
27
uric acid stones
for in ACIDIC urine, 100 times more soluble at pH > 6 risk factors: persistently acidic urine from diet high in protein, hyperuricemia, hyperuricosuria, treatment of lymphoma/leukemia treatment: alkalization of urine
28
urine alkalization agents
K+ citrate Na+ citrate Na+ bicarb
29
struvite stones
magnesium ammonium phosphate stones caused by infections with urease producing organisms (proteus) form staghorn calculi treatment: surgical removal and aggressive treatment of infection
30
calcium phosphate stones
form in ALKALINE unrine usually associated with metabolic disorders such as type 1 RTA (distal), primary hyperparathyroidism, or medullary sponge kidney treatment: managing the underlying disorder
31
cystine stones
autosomal recessive disorder known as cystinuria microscopic hexagonal crystals cystine more soluble in alkaline urine treatment: alkalization of urine, treat with drug Thiola to break down sulfide bond
32
clinical signs of urolithiasis
colicky flank pain radiating to groin or scrotum nausea and vomiting CVA tenderness hematuria
33
imaging for urolithiasis
non-contrast CT
34
lab workup for urolithiasis
UA + culture serum creatinine and electrolytes WBC count
35
indications for urgent intervention for urolithiasis
concomitant UTI, fever, or signs of sepsis renal azotemia (high serum Cr) solitary kidney (impending renal damage) intractable pain, nausea, or vomiting despite treatment patient preference
36
expectant management for urolithiasis
pain control with NSAIDs medical expulsive therapy with a blocker observation of 2-4 weeks
37
options for urgent surgical intervention of urolithiasis
placement of ureteral stent placement of percutaneous nephrostomy tube don't break the stone in case of releasing bacterial endotoxins causing sepsis
38
how to treat a kidney stone itself
oral dissolution therapy extracorporal shock wave lithotripsy ureteroscopy with intracorporal lithotripsy percutaneous nephrolithotomy
39
what workup is necessary when someone has recurrent stones?
metabolic work up
40
general dietary modifications to prevent kidney stones
increase fluid decrease dietary salt moderate animal protein increase dietary citrate
41
what is BPH
histologic diagnosis | increase in number of prostatic stromal and epithelial cells in the transition zone
42
lower urinary tract symptoms associated with BPH
phenotypic diagnosis | urinary frequency, urgency, slow stream, straining
43
pathophys of BPH
transition zone hyperplasia leads to increased resistance via: - bladder outlet obstruction from tissue (static) - increased smooth tone and resistance within the gland (dynamic)
44
storage symptoms
frequency urgency nocturia
45
emptying symptoms
weak stream intermittent flow straining to urinate incomplete emptying
46
indications for surgical management of BPH
``` gross hematuria UTI bladder stones urinary retention bladder diverticula ```
47
drug therapy options for BPH
alpha blocker: relax prostatic smooth muscle by blocking a1 adrenergic receptors 5 alpha reductase inhibitor: block conversion of testosterone to DHT and decrease prostate volume by 30%
48
surgical options in BPH
TURP (gold standard) open simple prostatectomy transurethral laser surgery minimally invasive therapy